Related Experiment Video
Updated: Nov 19, 2025

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
Published on: September 12, 2025
Primary Pulmonary B-Cell Lymphoma: A Review and Update
Francesca Sanguedolce1, Magda Zanelli2, Maurizio Zizzo3,4
1Pathology Unit, Azienda Ospedaliero-Universitaria, Ospedali Riuniti di Foggia, 71122 Foggia, Italy.
Primary pulmonary B-cell lymphomas (PP-BCLs) are lung-specific non-Hodgkin lymphomas. This review details the clinical and pathological features of common PP-BCLs, focusing on diagnosis and management challenges.
Area of Science:
- Pulmonary Medicine
- Hematology
- Oncology
Background:
- Primary pulmonary B-cell lymphomas (PP-BCLs) are extranodal non-Hodgkin lymphomas affecting the lung.
- These lymphomas present without evidence of disease elsewhere at diagnosis or for 3 months post-diagnosis.
- The most common types include primary pulmonary marginal zone lymphoma (PP-MZL), primary pulmonary diffuse large B-cell lymphoma (PP-DLBCL), and lymphomatoid granulomatosis (LYG).
Purpose of the Study:
- To review the clinical and pathological features of frequent primary pulmonary B-cell lymphomas.
- To critically analyze diagnostic and management challenges associated with these conditions.
- To emphasize the importance of a multidisciplinary approach in managing PP-BCLs.
Main Methods:
- Literature review of primary pulmonary B-cell lymphomas.
- Analysis of clinical presentation, morphology, and molecular features.
- Discussion of diagnostic workup and treatment strategies.
Main Results:
- PP-BCLs encompass distinct entities like PP-MZL, PP-DLBCL, and LYG, each with unique characteristics.
- Accurate diagnosis and risk assessment necessitate a collaborative effort among various medical specialists.
- Management strategies require careful consideration of the specific lymphoma subtype and patient factors.
Conclusions:
- Primary pulmonary B-cell lymphomas are a heterogeneous group requiring specialized diagnostic and management approaches.
- A multidisciplinary team is crucial for optimal patient care.
- Further research into the specific features and treatment of these rare lymphomas is warranted.
More Related Videos
07:43Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...